102 results
Page 4 of 6
8-K
EX-99.1
ygvt su41w1f31
1 May 19
Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab
7:45am
DEFA14A
m0i27l
30 Apr 19
Additional proxy soliciting materials
6:34am
DEFA14A
vmo7 ra9v2
30 Apr 18
Additional proxy soliciting materials
7:02am
10-K
EX-10.11
7bvd9
17 Mar 17
Annual report
12:00am
10-K
bdeesx1q86sr0v90
17 Mar 17
Annual report
12:00am
10-Q
xq39 comj8p4
14 Nov 16
Quarterly report
12:00am
10-12G/A
EX-10.19
frr11rh4h2ru6ojq wtc
19 Aug 16
Registration of securities (amended)
12:00am
10-12G/A
dmwel0qivp39gl
19 Aug 16
Registration of securities (amended)
12:00am
10-12G/A
ke5j4 nn2i9k2
29 Jul 16
Registration of securities (amended)
12:00am